{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:29:10Z","timestamp":1723595350682},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,13]]},"DOI":"10.7759\/cureus.66798","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T21:49:17Z","timestamp":1723585757000},"source":"Crossref","is-referenced-by-count":0,"title":["Anticoagulant Use in COVID-19 Patients: A Longitudinal Study From Zanjan, Iran"],"prefix":"10.7759","author":[{"given":"Vanoushe","family":"Azimi Pirsaraei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manizhe","family":"Jozpanahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koorosh","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Hamzeloo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyedeh Pegah","family":"Saeid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16727","article-title":"Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action","volume":"189","author":"Kollias A","year":"2020","unstructured":"Kollias A, Kyriakoulis KG, Dimakakos E, Poulakou G, Stergiou GS, Syrigos K. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Br J Haematol. 2020, 189:846-7. 10.1111\/bjh.16727","journal-title":"Br J Haematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-020-0767-8","article-title":"Coronavirus disease 2019 (COVID-19): a clinical update","volume":"14","author":"Zhou M","year":"2020","unstructured":"Zhou M, Zhang X, Qu J. Coronavirus disease 2019 (COVID-19): a clinical update. Front Med. 2020, 14:126-35. 10.1007\/s11684-020-0767-8","journal-title":"Front Med"},{"key":"ref3","article-title":"Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period","volume":"28","author":"Ozma MA","year":"2020","unstructured":"Ozma MA, Maroufi P, Khodadadi E, et al.. Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period. Infez Med. 2020, 28:153-65.","journal-title":"Infez Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review","volume":"75","author":"Bikdeli B","year":"2020","unstructured":"Bikdeli B, Madhavan MV, Jimenez D, et al.. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020, 75:2950-73. 10.1016\/j.jacc.2020.04.031","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-020-02125-4","article-title":"Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies and the lack of guidelines","volume":"50","author":"Porfidia A","year":"2020","unstructured":"Porfidia A, Pola R. Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies and the lack of guidelines. J Thromb Thrombolysis. 2020, 50:68-71. 10.1007\/s11239-020-02125-4","journal-title":"J Thromb Thrombolysis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00607-2020","article-title":"Pathogenesis of COVID-19 from a cell biology perspective","volume":"55","author":"Mason RJ","year":"2020","unstructured":"Mason RJ. Pathogenesis of COVID-19 from a cell biology perspective. Eur Respir J. 2020, 55:2000607. 10.1183\/13993003.00607-2020","journal-title":"Eur Respir J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.109975","article-title":"Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?","volume":"144","author":"Mohamed-Hussein AA","year":"2020","unstructured":"Mohamed-Hussein AA, Aly KM, Ibrahim MA. Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?. Med Hypotheses. 2020, 144:109975. 10.1016\/j.mehy.2020.109975","journal-title":"Med Hypotheses"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-020-02138-z","article-title":"Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum","volume":"50","author":"Barnes GD","year":"2020","unstructured":"Barnes GD, Burnett A, Allen A, et al.. Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum. J Thromb Thrombolysis. 2020, 50:72-81. 10.1007\/s11239-020-02138-z","journal-title":"J Thromb Thrombolysis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms J","year":"2020","unstructured":"Helms J, Tacquard C, Severac F, et al.. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020, 46:1089-98. 10.1007\/s00134-020-06062-x","journal-title":"Intensive Care Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok FA","year":"2020","unstructured":"Klok FA, Kruip MJ, van der Meer NJ, et al.. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020, 191:145-7. 10.1016\/j.thromres.2020.04.013","journal-title":"Thromb Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.551889","article-title":"Iran's approach to COVID-19: evolving treatment protocols and ongoing clinical trials","volume":"8","author":"Rahmanzade R","year":"2020","unstructured":"Rahmanzade R, Rahmanzadeh R, Hashemian SM, Tabarsi P. Iran's approach to COVID-19: evolving treatment protocols and ongoing clinical trials. Front Public Health. 2020, 8:551889. 10.3389\/fpubh.2020.551889","journal-title":"Front Public Health"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6697677","article-title":"Correlation between chest CT severity scores and the clinical parameters of adult patients with COVID-19 pneumonia","volume":"2021","author":"Saeed GA","year":"2021","unstructured":"Saeed GA, Gaba W, Shah A, et al.. Correlation between chest CT severity scores and the clinical parameters of adult patients with COVID-19 pneumonia. Radiol Res Pract. 2021, 2021:6697677. 10.1155\/2021\/6697677","journal-title":"Radiol Res Pract"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.05.044","article-title":"COVID-19: transmission, prevention, and potential therapeutic opportunities","volume":"508","author":"Lotfi M","year":"2020","unstructured":"Lotfi M, Hamblin MR, Rezaei N. COVID-19: transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta. 2020, 508:254-66. 10.1016\/j.cca.2020.05.044","journal-title":"Clin Chim Acta"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2020.05.045","article-title":"The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects","volume":"21","author":"Bonanad C","year":"2020","unstructured":"Bonanad C, Garc\u00eda-Blas S, Tarazona-Santabalbina F, et al.. The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects. J Am Med Dir Assoc. 2020, 21:915-8. 10.1016\/j.jamda.2020.05.045","journal-title":"J Am Med Dir Assoc"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-020-00330-7","article-title":"Sex differences in severity and mortality from COVID-19: are males more vulnerable?","volume":"11","author":"Pradhan A","year":"2020","unstructured":"Pradhan A, Olsson PE. Sex differences in severity and mortality from COVID-19: are males more vulnerable?. Biol Sex Differ. 2020, 11:53. 10.1186\/s13293-020-00330-7","journal-title":"Biol Sex Differ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.34172\/aim.2020.102","article-title":"Clinical characteristics and outcomes of 905 COVID-19 patients admitted to Imam Khomeini Hospital Complex in the capital city of Tehran, Iran","volume":"23","author":"Allameh SF","year":"2020","unstructured":"Allameh SF, Nemati S, Ghalehtaki R, et al.. Clinical characteristics and outcomes of 905 COVID-19 patients admitted to Imam Khomeini Hospital Complex in the capital city of Tehran, Iran. Arch Iran Med. 2020, 23:766-75. 10.34172\/aim.2020.102","journal-title":"Arch Iran Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100789","article-title":"COPD and the risk of poor outcomes in COVID-19: a systematic review and meta-analysis","volume":"33","author":"Gerayeli FV","year":"2021","unstructured":"Gerayeli FV, Milne S, Cheung C, et al.. COPD and the risk of poor outcomes in COVID-19: a systematic review and meta-analysis. EClinicalMedicine. 2021, 33:100789. 10.1016\/j.eclinm.2021.100789","journal-title":"EClinicalMedicine"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v92i3.10630","article-title":"Predictors of clinical outcomes in adult COVID-19 patients admitted to a tertiary care hospital in India: an analytical cross-sectional study","volume":"92","author":"Chauhan NK","year":"2021","unstructured":"Chauhan NK, Shadrach BJ, Garg MK, et al.. Predictors of clinical outcomes in adult COVID-19 patients admitted to a tertiary care hospital in India: an analytical cross-sectional study. Acta Biomed. 2021, 92:e2021024. 10.23750\/abm.v92i3.10630","journal-title":"Acta Biomed"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa403","article-title":"Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis","volume":"76","author":"Kashour Z","year":"2021","unstructured":"Kashour Z, Riaz M, Garbati MA, et al.. Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis. J Antimicrob Chemother. 2021, 76:30-42. 10.1093\/jac\/dkaa403","journal-title":"J Antimicrob Chemother"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2021.1848545","article-title":"Efficacy and safety of lopinavir\/ritonavir in the treatment of COVID-19: a systematic review","volume":"19","author":"Joseph BA","year":"2021","unstructured":"Joseph BA, Dibas M, Evanson KW, et al.. Efficacy and safety of lopinavir\/ritonavir in the treatment of COVID-19: a systematic review. Expert Rev Anti Infect Ther. 2021, 19:679-87. 10.1080\/14787210.2021.1848545","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.20.20157891","article-title":"Intravenous immunoglobulin (IVIG) significantly reduces respiratory morbidity in COVID-19 pneumonia: a prospective randomized trial","author":"Sakoulas G","year":"2020","unstructured":"Sakoulas G, Geriak M, Kullar R, et al.. Intravenous immunoglobulin (IVIG) significantly reduces respiratory morbidity in COVID-19 pneumonia: a prospective randomized trial. medRxiv. 2020, 10.1101\/2020.07.20.20157891","journal-title":"medRxiv"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107205","article-title":"Evaluating the effects of intravenous immunoglobulin (IVIg) on the management of severe COVID-19 cases: a randomized controlled trial","volume":"90","author":"Tabarsi P","year":"2021","unstructured":"Tabarsi P, Barati S, Jamaati H, et al.. Evaluating the effects of intravenous immunoglobulin (IVIg) on the management of severe COVID-19 cases: a randomized controlled trial. Int Immunopharmacol. 2021, 90:107205. 10.1016\/j.intimp.2020.107205","journal-title":"Int Immunopharmacol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57090931","article-title":"Aspirin is related to worse clinical outcomes of COVID-19","volume":"57","author":"Kim I","year":"2021","unstructured":"Kim I, Yoon S, Kim M, Lee H, Park S, Kim W, Lee S. Aspirin is related to worse clinical outcomes of COVID-19. Medicina (Kaunas). 2021, 57:931. 10.3390\/medicina57090931","journal-title":"Medicina (Kaunas)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.024530","article-title":"Aspirin therapy on prophylactic anticoagulation for patients hospitalized with COVID-19: a propensity score-matched cohort analysis of the HOPE-COVID-19 Registry","volume":"11","author":"Santoro F","year":"2022","unstructured":"Santoro F, N\u00fa\u00f1ez-Gil IJ, Vitale E, et al.. Aspirin therapy on prophylactic anticoagulation for patients hospitalized with COVID-19: a propensity score-matched cohort analysis of the HOPE-COVID-19 Registry. J Am Heart Assoc. 2022, 11:e024530. 10.1161\/JAHA.121.024530","journal-title":"J Am Heart Assoc"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2021-001785","article-title":"Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study","volume":"8","author":"Matli K","year":"2021","unstructured":"Matli K, Chamoun N, Fares A, et al.. Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study. Open Heart. 2021, 8:e001785. 10.1136\/openhrt-2021-001785","journal-title":"Open Heart"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-022-01809-8","article-title":"Efficacy of different anticoagulant doses for patients with COVID-19: a systematic review and network meta-analysis","volume":"50","author":"Yasuda H","year":"2022","unstructured":"Yasuda H, Mayumi T, Okano H. Efficacy of different anticoagulant doses for patients with COVID-19: a systematic review and network meta-analysis. Infection. 2022, 50:1453-63. 10.1007\/s15010-022-01809-8","journal-title":"Infection"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.07.030","article-title":"CT lung lesions as predictors of early death or ICU admission in COVID-19 patients","volume":"26","author":"Ruch Y","year":"2020","unstructured":"Ruch Y, Kaeuffer C, Ohana M, et al.. CT lung lesions as predictors of early death or ICU admission in COVID-19 patients. Clin Microbiol Infect. 2020, 26:1417.e5-8. 10.1016\/j.cmi.2020.07.030","journal-title":"Clin Microbiol Infect"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244171","article-title":"Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru","volume":"15","author":"Mej\u00eda F","year":"2020","unstructured":"Mej\u00eda F, Medina C, Cornejo E, et al.. Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru. PLoS One. 2020, 15:e0244171. 10.1371\/journal.pone.0244171","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/263779-anticoagulant-use-in-covid-19-patients-a-longitudinal-study-from-zanjan-iran","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T21:49:24Z","timestamp":1723585764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/263779-anticoagulant-use-in-covid-19-patients-a-longitudinal-study-from-zanjan-iran"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.66798","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,13]]}}}